Get access to our best features
Get access to our best features
Published 2 months ago

Takeda To Manufacture 50% Of Its Dengue Vaccines In India

Summary by Ground News
Japanese drugmaker Takeda Pharmaceutical Co. announced a strategic partnership with Indian vaccine and biologics company Biological E. Ltd. The Indian partner is expected to "scale up its production capacity to potentially reach 50 million doses annually" The vaccine is currently approved in more than 30 countries, including the European Union, the United Kingdom and Brazil.

0 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)